Скачать или смотреть Experience with Patient Involvement in HTA processes

EUPATI publishes guidance for patient invollvement in HTA as an open-access peer-reviewed article with Frontiers in Medicine https://www.frontiersin.org/articles/...

The main aim of health technology assessment (HTA) is to inform decision making by health care policy makers. It is a systematic process that evaluates the use of health technologies and generally involves a critical review of international evidence related to clinical effectiveness of the health technology vs. the best standard of care. It can also include an evaluation of cost effectiveness, and social and ethical impacts in the local health care system. The HTA process advises whether or not a health technology should be used, and if so, how it is best used and which patients are most likely to benefit from it. The importance of patient involvement in HTA is becoming widely recognized, for scientific and democratic reasons. The extent of patient involvement in HTA varies considerably across Europe. Commonly HTA is still focused on quantitative evidence to determine clinical and/or cost effectiveness, but the interest in understanding patients' experiences and preferences is increasing. Some HTA bodies provide support for participation in their processes, but again this varies widely across Europe. The involvement of patients in HTA is determined at the national and regional level, and is not subject to any European-wide legislation. The guidance presented in this video was developed as part of the work of the European Patients' Academy on Therapeutic Innovation (EUPATI) www.eupati.eu and covers the interaction between HTA bodies and patients and their representatives when medicines are being assessed.
How are patients and patient organisations getting involved in Health Technology Assessment to improve accessibility to medicines?

The guidance can also be viewed on the EUPATI webpage at https://www.eupati.eu/health-technolo...